The short version

From the latest prices and each company's SEC filings. Who's ahead on each measure, not which to buy.

  • Intuitive Surgical is the larger company, worth $153.4B, about 9.9 times Solventum.
  • Intuitive Surgical grew revenue faster over the last year (+18.5% vs +2.2%).
  • Intuitive Surgical keeps more of each dollar of revenue as operating profit (31.3% vs 25.0%).
  • On earnings, Solventum is the cheaper stock (10.9x vs 52.8x).

Side by side

The stronger figure is shaded where higher (or, for valuation multiples, lower) reads as better. How the implied growth works.

MeasureISRGSOLV
Market cap$153.4B$15.5B
Share price$423.96$87.29
Revenue (last fiscal year)$10.1B$8.3B
Free cash flow (last fiscal year)$2.5B-$10M
Revenue growth, last year+18.5%+2.2%
Revenue growth per year, last 5 fiscal years+15.2%+0.8%
Operating margin31.3%25.0%
Net margin28.4%17.3%
Return on equity17.3%29.9%
P/E (trailing)52.8x10.9x
Price / free cash flow61.6x—
EV / EBITDA32.5x9.17x
FCF growth the price implies19.8%—
Dividend yield——
Debt / equity0.14x1.97x
Fundamental gradeBC
Superinvestors holding it76
Insider purchases, last 12 months81

Results from SEC filings

Revenue and free cash flow by fiscal year, from each company's 10-K filings.

Intuitive Surgical

YearRevenueFree cash flowOp. margin
2021$5.7B$1.7B31.9%
2022$6.2B$958M25.3%
2023$7.1B$750M24.8%
2024$8.4B$1.3B28.1%
2025$10.1B$2.5B29.3%

Solventum

YearRevenueFree cash flowOp. margin
2022$8.1B$1.4B20.8%
2023$8.2B$1.6B20.6%
2024$8.3B$805M12.6%
2025$8.3B-$10M26.2%

Where the revenue comes from

Intuitive Surgical · by products, 2025

Instruments and accessories$6.0B60%
Systems$2.5B25%
Service$1.6B16%

Solventum · by segments, 2025

MedSurg$4.8B60%
Health Information Systems$1.4B17%
Dental Solutions$1.3B17%
Purification and Filtration$497M6%
Compare them in fullFifteen years of statements, quarterly results, DCF and IRR models, and any number of peers side by side.
Open ISRG in Investingly

Questions

Which is bigger, Intuitive Surgical or Solventum?

Intuitive Surgical (ISRG), at $153.4B against $15.5B.

Is ISRG or SOLV cheaper?

By trailing P/E, Solventum (10.9x) is cheaper than Intuitive Surgical (52.8x). A lower multiple can also mean the market expects less growth.

Which grows faster, ISRG or SOLV?

Intuitive Surgical: revenue grew +18.5% over the last year, against +2.2%.

Prices and ratios as of the last daily update; statements from SEC filings. Information only, not investment advice.